Grant: Engage Grants Program
University of Toronto
$25,000.00
Characterization of the mechanisms of action of nanobodies that interfere with the infection of chicken gut epithelial cells by Salmonella
EF 2015-16
Résumé
The human pathogenic bacteria Salmonella enterica is commonly found in the intestine of poultry. Consumption of infected chicken and eggs, and its derivatives, is the main and most important source of Salmonella infection outbreaks in humans.
Salmonellosis produces diarrhoea, fevers and abdominal cramps. Most people recover after few days without treatment. However, in some cases the occurrence of severe diarrhea and dehydration followed by systemic spreading of the infection turns Salmonellosis into a life-threatening disease that requires hospitalization. The elderly, infants, and patients with impaired immune systems are more susceptible to the severe form of this disease and in risk of death, unless treated promptly with the correct antibiotics. At present no widely effective strategy is available to interfere with Salmonella colonization of broiler chickens to prevent the infection in humans.
Nanobodies, the smallest antibodies known in nature, are produced by members of the family Camelidae (like camels, llamas and alpacas) and sharks. This recently discovered antibodies present immunological and biotechnological advantages respect to the conventional antibodies. Indeed, nanobodies can be easily expressed in bacteria and produced in large quantities at a significantly lower cost.[11].
Our industrial partner, AbCelex developed a library of nanobodies, against Salmonella. Thus, the objective of the studies proposed here will be to identify in AbCelex's nanobodies library those antibodies that can protect chicken against Salmonella infection, and investigate their mechanisms of action. The outcome of these studies will help in understanding the mechanism of action selected anti- Salmonella nanobodies and to facilitate commercial implementation of nanobody-based technologies for controlling and detecting Salmonella in the food chain.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
484333-2015
Name nom
Terebiznik, Mauricio
Department département
Biological Sciences (Scarborough)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
6102
Research subject group en
Food science and technology
Research subject group fr
Science et technologie de l'alimentation
Research subject en
Food microbiology
Research subject fr
Microbiologie alimentaire
Partie
1
Nb partie
1
Application title
Characterization of the mechanisms of action of nanobodies that interfere with the infection of chicken gut epithelial cells by Salmonella
Keyword
NSERC
Application summary
The human pathogenic bacteria Salmonella enterica is commonly found in the intestine of poultry. Consumption of infected chicken and eggs, and its derivatives, is the main and most important source of Salmonella infection outbreaks in humans.
Salmonellosis produces diarrhoea, fevers and abdominal cramps. Most people recover after few days without treatment. However, in some cases the occurrence of severe diarrhea and dehydration followed by systemic spreading of the infection turns Salmonellosis into a life-threatening disease that requires hospitalization. The elderly, infants, and patients with impaired immune systems are more susceptible to the severe form of this disease and in risk of death, unless treated promptly with the correct antibiotics. At present no widely effective strategy is available to interfere with Salmonella colonization of broiler chickens to prevent the infection in humans.
Nanobodies, the smallest antibodies known in nature, are produced by members of the family Camelidae (like camels, llamas and alpacas) and sharks. This recently discovered antibodies present immunological and biotechnological advantages respect to the conventional antibodies. Indeed, nanobodies can be easily expressed in bacteria and produced in large quantities at a significantly lower cost.[11].
Our industrial partner, AbCelex developed a library of nanobodies, against Salmonella. Thus, the objective of the studies proposed here will be to identify in AbCelex's nanobodies library those antibodies that can protect chicken against Salmonella infection, and investigate their mechanisms of action. The outcome of these studies will help in understanding the mechanism of action selected anti- Salmonella nanobodies and to facilitate commercial implementation of nanobody-based technologies for controlling and detecting Salmonella in the food chain.